Modular Medical Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
MODD Nasdaq 2835 https://www.modular-medical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Modular Medical Inc

Modular Medical Provides Update on FDA Submission Strategy - Jan 25th, 2023 2:00 pm
Modular Medical Announces Product Testing Update - Nov 28th, 2022 2:29 pm
Modular Medical Announces Participation at Upcoming Investor Conferences - Nov 23rd, 2022 4:20 pm
Modular Medical Provides Product Update - Oct 3rd, 2022 10:00 am
Dr. Anne Peters Joins the Modular Medical Advisory Board - Aug 11th, 2022 12:30 pm
Modular Medical Appoints Kevin Schmid as Chief Operating Officer - Jul 26th, 2022 12:15 pm
We Think Modular Medical (NASDAQ:MODD) Needs To Drive Business Growth Carefully - Jun 30th, 2022 11:46 am
Modular Medical to Present at LD Micro Invitational XII Investor Conference - Jun 2nd, 2022 8:01 pm
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 - May 16th, 2022 5:20 pm
Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022 - May 12th, 2022 8:00 pm
2 Stocks Oppenheimer Sees Surging Over 80% - May 6th, 2022 10:53 am
Modular Medical Announces $8 Million Registered Direct Offering - May 3rd, 2022 12:00 pm
Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference - Mar 3rd, 2022 9:01 pm
Modular Medical Appoints James "Jeb" Besser as Chief Executive Officer - Feb 24th, 2022 1:00 pm
Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market - Feb 10th, 2022 1:00 pm